Advertisement
Advertisement

KMDA

KMDA logo

Kamada Ltd

7.76
USD
Sponsored
-0.67
-7.89%
May 13, 10:27 UTC -4
Open

Kamada Ltd Profile

About

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona, Israel.

Info & Links

CEO

Amir London

Headquarters

2 HOLTZMAN ST., SCIENCE PARK
REHOVOT, L3 7670402, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kamada.com

Auditor

KOST FORER GABBAY & KASIERER

Share holders

1

Employees

462

Kamada Ltd Statistics

Valuation Measures

Market Capitalization2

447.93M

Enterprise Value

382.39M

Enterprise Value/EBITDA(ttm)

9.29

Price to Earnings Ratio(ttm)

24.31

Price to Sales(ttm)

2.71

Price to Book(mrq)

1.82

Price to Cash(ytd)

13.94

Profitability

Gross Margin(ttm)

42.36%

Operating Margin(ttm)

11.19%

Profit Margin(ttm)

11.18%

Return on Equity(ttm)

7.72%

Return on Invested Capital(ttm)

7.73%

Return on Assets(ttm)

5.39%

Income Statement

Revenue(ttm)

180.46M

Revenue Per Share(ttm)

3.13

Gross Profit(ttm)

76.41M

EBITDA(ttm)3

41.15M

Net Income Available to Common(ttm)

20.20M

Diluted EPS(ttm)

0.35

Share Statistics

Beta (5Y Monthly)

0.93

52-Week Change

13.86%

S&P 500 52-Week Change

25.77%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.69M

Dividend Yield

2.20%

Float4

36.75M

% Held by Insiders

36.10%

% Held by Institutions

20.38%

Balance Sheet

Total Cash(mrq)

75.47M

Total Cash Per Share(mrq)

1.31

Total Debt(mrq)

9.92M

Total Debt/Equity(mrq)

3.69%

Current Ratio(mrq)

4.07%

Quick Ratio(mrq)

2.28%

Book Value Per Share(mrq)

4.66

Cash Flow

Operating Cash Flow Per Share(ytd)

0.44

Free Cash Flow(ytd)

15.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement